Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hypertension
- Impaired Liver Function
- Preeclampsia
- Proteinuria
- Pulmonary Edema
- Renal Insufficiency
- Thrombocytopenia
- Type
- Observational
- Design
- Observational Model: Family-BasedTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 45 years
- Gender
- Only males
Description
Eligible subjects will provide written informed consent after which demographic and baseline clinical data will be recorded. Collection of whole blood and urine samples will be performed at one or more clinic visits from pregnant women carrying a single fetus with no known fetal abnormalities. Inter...
Eligible subjects will provide written informed consent after which demographic and baseline clinical data will be recorded. Collection of whole blood and urine samples will be performed at one or more clinic visits from pregnant women carrying a single fetus with no known fetal abnormalities. Interim study visits will continue every 14 days [+/- 3 days] until the subject either: 1) reaches 37 0/7 weeks' gestation, 2) develops Pre-E, 3) delivers, or 4) is lost to follow-up. In addition, a group of pregnant women diagnosed with Pre-E will be enrolled as positive control cases.
Tracking Information
- NCT #
- NCT02780414
- Collaborators
- Not Provided
- Investigators
- Study Director: Peter Stiegler, PhD Progenity, Inc.
Get Well Soon